Will Strong Segmental Performance Drive MCK's Top Line in Q2?

Key Takeaways MCK's Q2 revenues are projected at $104.66B, up 11.8%, with EPS expected to rise 26.2% to $8.92.MCK's U.S. Pharma and RxTS segments likely fueled broad-based growth across specialty and digital services.Automation gains and cost control might have offset MCK's integration expenses from recent acquisitions.McKesson Corporation (MCK) is scheduled to report second-quarter fiscal 2026 results on Nov. 5, after market close.The company delivered an earnings surprise of 0.36% in the last reported qua ...